Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out post on stocktwits about DHS phase 2 inovio
https://stocktwits.com/message/244951389
See link below, it shows that study is supposed to be completed this month.
https://clinicaltrials.gov/ct2/show/study/NCT04311697?term=Aviptadil&draw=2&rank=2
Scott is wrong in that Zimmer can't go directly to Amedica. Has to go thru CTL as exclusive broker.
Actually Scott is correct. CTL is OEM broker. Any other players that want SiN coating for their products has to go thru CTL for Amda to manufacture but Amda has to pay CTL a commission on each unit.
1.8 Exclusive Brokerage.
(a) Seller hereby appoints, designates, and fully licenses (under the SN Manufacturing Patents and any other rights) Buyer, during the term described in Section 1.8(g) below, as its exclusive broker to offer for sale, and sell, Seller’s manufacturing services to third party developers of spinal implants and spinal devices that incorporate silicon nitride technology (the “Third Party Products”).
(b) Seller acknowledges and agrees that Buyer does not, has not, and will not promise or guarantee to sell any product or service, and Seller further acknowledges and agrees that (i) all sales initiatives undertaken by Buyer hereunder are done so on a best efforts basis with no guarantee of success, (ii) Buyer is an independent company with no affiliation to any prospective purchaser of Seller’s manufacturing services, and (iii) Buyer has no buying authority and cannot make any commitments on behalf of any prospective purchaser of Seller’s manufacturing services.
(c) Buyer shall market, solicit, and attempt to secure purchase orders for the manufacture of Third Party Products. Seller shall have the right, in its sole discretion, to reject any order, in whole or in part, with or without cause. Buyer shall immediately communicate to the Seller all offers for Seller’s manufacturing services received from any prospective purchaser and, upon instruction from the Seller, shall communicate to such prospective purchaser the Seller’s acceptance or non-acceptance of such offer. The Seller will copy Buyer on all correspondence with any purchaser or prospective purchaser of Seller’s manufacturing services regarding purchase orders for Third Party Products.
(d) Any negotiations by Buyer on behalf of Seller shall be conducted in accordance with such prices, terms, and conditions as are specified by Seller. Buyer shall not incur any expenses or enter into any obligations without the Seller’s authorization and direction.
(e) In consideration of the brokerage services performed by Buyer pursuant to this Section 1.8, Seller shall pay to Buyer a commission to be negotiated by Buyer and Seller on the revenues from Third Party Products. Seller will provide Buyer with a copy of all net invoiced sales on a monthly basis. Buyer’s right to payment shall be determined on the date an order is transmitted by a purchaser or prospective purchaser. Seller shall pay Buyer the commission specified herein no later than the thirtieth (30th) day after the Seller receives payment from the purchaser for the applicable order. All payments by Seller to Buyer hereunder shall be in US Dollars and made by electronic transfer or a check made payable to “CTL MEDICAL CORPORATION” and delivered in accordance with Section 11.2.
I agree with you FS15. No way CTL is going to update competitors product with SiN. They would be only undercutting sales of their own implants. Sonny mentioned CTL exclusivity this morning.
Looks like they will only be able to license Si3N4 for non-spinal indications since the gave exclusivity to CTL for 10 years.
From company SEC filing.
The Company will continue to manufacture the Silicon Nitride Products for CTL for ten years following the closing of the Transactions (the “Closing”) pursuant to an exclusive manufacturing arrangement described in the Purchase Agreement, and the Company will continue to manufacture and own all rights to silicon nitride products for other non-spinal biomedical applications (the “Amedica Products”)following the Closing. In addition, the Company will continue to own the patents claiming the manufacture of the Silicon Nitride Products and the Amedica Products and the related know how required for such manufacture.
If something positive was going to be announced then you would think Sonny would be happy to answer questions during CC. When a company doesn't allow questions that is usually a bad sign.
Boston,
The difference is previously OMID said that he had a contact that was participating in the offering. Today he said that "I can convert anytime" indicating that he is the one participating.
I also wonder why he picked May 11th as date of record when there were only 4.4 million shares. A week later the outstanding shares increased to 7.2 million.
Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Shares of common stock that may be acquired by an individual or group within 60 days of May 18, 2018, pursuant to the exercise or vesting of options or warrants or conversion of convertible promissory notes, are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Percentage of shares beneficially owned is based on 7,224,240 shares issued and outstanding on May 18, 2018.
Just need some positive Japan news and this can really fly. My shares are back in the money now. $300k swing from yesterday to today. Didn't think it was going to happen.
This is an anonymous board, so it's up to you what you want to believe or not. No skin off my back if you don't believe me. Only about 2 months left for Sonny to hold shareholder meeting.
I'm not the one putting $10 price tag on it. I was just replying to your quote and that I would vote Yes even though I don't like the price tag.
I wouldn't like it, but I would vote Yes since I still would make decent money. Also when there is group shareholder lawsuit, the attorneys get most of the money. Shareholders get pennies on the dollar. I have been involved in a couple of them about 15 years ago. One of them, I had over a quarter of million dollars invested and when lawsuit was in favor of investors, I got a whopping $8400 dollars back.
I would vote Yes for $10 a share since my cost average is low, but I would like a higher return on my money than that.
That is possible before the meeting deadline. I think the SEC only takes about 30 days max. to approve S-1 before it can become effective. Then Sonny could have his special investors pay for and convert the warrants before scheduling and setting a record date of shares.
Yes, I know that. But isn't part of the offering also for warrants which can be converted to regular shares?
Exactly. Retail is not a threat if buyout/merger. But they are a threat if meeting happens to vote for board members.
A lot of companies have joint agreements and that doesn't stop them from going it alone. They just have to pay royalties or commision.
If the price is right then I think of a lot them would also vote if there is a merger/buyout.
Food for thought. CL said the S-1 is so that they can control of shares if there is a merger so that there would be enough votes for a Yes. I know that me and a few of my friends which own a little less than 5% each would vote Yes if there was a merger at the right price even though we all voted No for the reverse split. Most investors voted No on the reverse split since most stocks go up only for a little while after the reverse then the stock usually starts dropping again for new lows. I think most of the investors that voted No also would vote Yes if there was a buyout/merger for the right price. So this has me wondering if there is a buyout/merger, then maybe it is a low ball offer or they just want control of the votes so that if they have a meeting to re-elect board members, they won't have a problem. Then Sonny can keep running the show.
My friend who lives in London can buy, sell, or sell short Amedica. His trade goes thru on the american exchange. He has a little over 100k shares. So I know that it can be bought or sold in Europe. I haven't spoken to him in awhile, so I would have to contact to get more info.
Since amedica let the lei expire,the stock can't be bought or shorted thru the European exchanges. Investors from Europe still can buy short amedica if they buy direct thru US exchanges.
Like I have said in the past. Sonny is just going to keep running the show. More proof with today's filing that they didn't use all the cash from warrant exercise to pay of the note which some people thought was delaying the so called merger. He was delaying the annual meeting as long as possible since he was worried that he won't get enough votes for the chairman position. Remember how hard it was to get yes votes for the reverse split. Now with the new filing, he will be able to get enough votes since the shares/warrants will given to his cronies.
That's very normal for the stock on low volume days since the float is so small after reverse split.
Weigo/China deal back on the table from latest filing?
Yes, but if shareholders can get new board members then the new board members can appoint a different ceo. Me & few other shareholders that hold slightly less than 5% each have made it clear to that is the direction that we are heading for months. I think that is why the delay over meeting more than M/A or BO scenario.
My point is that Sonny has been delaying the annual meeting because he knows that he wouldn't get enough votes to stay in power with all the disgruntled investors. Remember that he was barely able to get the reverse split approved by delaying multiple times and finding more votes. Don't you find it interesting that one specific investor is getting the option of converting warrants for approximately 1.4 million shares? I think that now he would have enough votes to hold annual meeting. Just shortly before nasdaq extension news.
Quote:
" The company fully intends to hold an annual meeting of shareholders by the due date, and otherwise remain in compliance with NASDAQ rules and regulations"
If he does hold the meeting by the deadline, then that means he is going to keep running the show. No M/A or BO
If that was the case with revenue that high in 4th quarter, then they should have had no problem with payment of Hercules. Why involve Anson to get rid of Hercules.
Will they actually be able to raise enough money to pay off the notes from investors? Even if investors opt in for the special rights, will they be willing to pay for the shares even if at a steep discount since they have been already burned before. Also a lot investors even if they opt in might already be tapped out of money to buy more shares. A lot investors will probably be sacred to do so since it will be essentially diluting themselves.
If this is opportunity for management to buy, wouldn't it be insider trading if the supposed M/A is not far away?
Usually share holders get diluted indirectly. In this case the shareholders are going to pay for the dilution directly when they opt to convert the shares at a set price which is usually at a steep discount. Starting to sound more like that Sonny wants to pay off Anson so that he can continue to run the company himself. Essentially shareholders will be diluting themselves.
Yes, prelim S-1. Final S-1 probably afters hours on Friday. Sonny likes to fart around 5:30 pm after hours on Fridays.
S-1 filing EOM
Looks like FDA approval is going to be delayed. Hopefully he doesn't take a few months to answer questions like last time & no labeling issues.
JDA is only is good if it produces some upfront money from the partner. Have any previous JDA's produced any money?
Since cash is running low. Sonny might do a P/O. Shabby will short into the P/O. They always know before retail.
Sonny is the type of guy that likes to prove the concept by research and publishing reports. He is not a ceo type of guy who can run a profitable business. I don't think he is going to sell the company or merge with another company. Wait till February when the FDA wants more info or there is a delay. Then you will see a private placement offering. Remember the theory that the new partner or company was going to submit the new CSC submission a couple of months ago. If merger or buyout was going to happen then Sonny would have probably waited a little longer for submission and let the new company handle it.
Means that Sonny is going to keep running the show. I think that there will be a private offering in the next month or two. Boston and Cl can't see any negatives since this is their only position and are holding the bag.
They are at CNS on the 12th also. So are they going ignore nasdaq meeting also.